ArticleDysphagia2026
Swallowing Impairments in Patients with Myasthenia Gravis: A Scoping Review.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This scoping review aims to describe the oropharyngeal and esophageal swallowing profiles of individuals with Myasthenia Gravis (MG). Given the high prevalence of dysphagia in this population, this review seeks to synthesize existing literature on swallowing impairments and highlight the need for early identification in dysphagia management. This scoping review was conducted in accordance with Joanna Briggs Institute methodology for scoping reviews. Four databases were systematically searched to identify studies that examined swallowing impairments in MG using instrumental assessments. Studies were screened and selected if they utilized instrumental assessments, including Videofluoroscopic Swallowing Study (VFSS), Fiberoptic Endoscopic Evaluation of Swallowing (FEES), and/or esophageal manometry. Included studies were analyzed by two independent reviewers to provide a comprehensive overview of dysphagia across oral, pharyngeal, and esophageal domains using Covidence. A total of 4,305 manuscripts were identified; 1,959 remained after removing duplicates. Following screening titles, abstracts, and full texts, 13 remained. Findings indicate that MG-associated dysphagia affects all domains of swallowing. Disease severity, classified using the Myasthenia Gravis Foundation of America (MGFA) and Osserman classification, was associated with increased dysphagia severity. Studies reported a significant prevalence of silent aspiration, with 75% of silent aspirators developing aspiration pneumonia. This review highlights the high prevalence of dysphagia in MG and the importance of objective assessments in identifying swallowing impairments. Routine instrumental evaluations are essential for managing dysphagia and preventing serious complications such as aspiration pneumonia and myasthenic crisis. Future research should focus on standardizing dysphagia screening and assessment tools for MG.
Indexed as
Identifiers
41361129What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.